pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. The genomic medicine journey.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

DECEMBER 21, 2021

In a recent webinar held by pharmaphorum, in partnership with IQVIA, a discussion was held looking at how to make academic and commercial medical research more efficient, while also looking at the opportunity of genomic data to bring benefits to patients and healthcare systems. The potential to leverage genomic data.

Development 98

Development Genome Genomics Drugs 98

pharmaphorum

OCTOBER 5, 2021

The time of individuals relying entirely on face-to-face interaction with their doctors is long past. Although junior doctors may be more digitally native, it is possible that there will be more widespread adoption in experienced medical professionals, because they understand the medical and patient end value better.

Doctors 132

Doctors Doctor Marketing Development 132

pharmaphorum

SEPTEMBER 1, 2020

Another military man in the drugs business was Edward Robinson Squibb, who as a naval doctor during the Mexican-American war of 1846–1848 threw the drugs he was supplied with overboard due to their low quality. Thalidomide and the development of drug safety regulation and monitoring. George Merck on the cover of Time magazine.

Medicine 145

Medicine Insulin Pharmacy Drugs 145